CAPTRUST FINANCIAL ADVISORS - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 85 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$17,101
-15.7%
21,9240.0%0.00%
Q2 2023$20,280
-14.0%
21,924
+1.4%
0.00%
Q1 2023$23,568
+12.2%
21,622
+10.2%
0.00%
Q3 2022$21,000
+162.5%
19,622
+324.5%
0.00%
Q2 2022$8,000
-20.0%
4,6220.0%0.00%
Q1 2022$10,000
+150.0%
4,622
+391.7%
0.00%
Q4 2021$4,000
-20.0%
9400.0%0.00%
Q3 2021$5,000
+25.0%
9400.0%0.00%
Q2 2021$4,000
-20.0%
9400.0%0.00%
Q1 2021$5,0009400.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders